ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Exact Sciences Launches New Spanish-Language Campaign to Increase Colon Cancer Screening in Hispanic Community

(BPT) - The facts around colon cancer, also known as colorectal cancer, are too staggering to ignore. It is the second leading cause of cancer-related death in the United States.1

Yet despite recommendations, less than half (49%) of eligible Hispanic adults - there are currently over 17 million Hispanic people in the U.S. over the age of 45 - undergo recommended screening.2,3 Barriers to screening include language and cultural differences as well as lack of access, but the biggest reason may be that people don't realize that colon cancer screening should start at age 45.

To help increase awareness around colon cancer screening, Exact Sciences has launched its first-ever Spanish-language campaign tailored to the Hispanic community timed to Hispanic Heritage Month. The campaign, which will appear on television, radio and social media, includes important information about the Cologuard® test - a non-invasive, effective and affordable at-home colon cancer screening test.

Early detection of colon cancer before a person has symptoms arise can significantly improve treatment options and survival rates.4 The American Cancer Society recommends that anyone at average risk and aged 45+ get screened.4 When found at an early stage, the 5-year relative survival rate is close to 90%. However, if the cancer is not caught before it spreads to distant parts of the body, that survival rate drops to around 14%.5

'Education and early screening are vital in catching this disease early and improving outcomes,' said Veronica Descotte, Chief Strategy Officer at Exact Sciences. 'Our goal is to ensure that everyone, particularly in the Hispanic community, has access to the information and resources they need.'

One Patient's Story

Colon cancer survivor and advocate, Marielle, noticed troubling health symptoms back in 2017. It started with blood in her stool, then stomach pain, and, eventually, sudden weight loss of 20 pounds in just a few weeks. Despite her concerns, the medical advice she received didn't lead to answers. It wasn't until she pushed her doctor for further testing that the 36-year-old Latina discovered she had colon cancer.

'I think many people in my community would be surprised to know that colon cancer can be fully cured in early stages and even prevented through the removal of growths called polyps,' said Marielle, Director of Programs & Advocacy at a national peer support organization. 'The reality is that it's not always possible to take time off from work to get into the doctor's office. Having convenient and non-invasive options for testing that can be done in the privacy of your own home is a game changer.'

Marielle and her familly posing by a fountain.
Photo courtesy Marielle, colon cancer survivor and advocate.

A Call to Action

As we look to the future, the efforts of organizations like Exact Sciences and advocates like Marielle aim to create a world where colon cancer is detected earlier, treated more effectively, and ultimately prevented.

If you're 45 or older, talk to your doctor about available colon cancer screening options that are right for you. Learn more by visiting www.cologuard.com.

The Cologuard test is intended to screen adults 45 years of age and older who are at average risk for colorectal cancer by detecting certain DNA markers and blood in the stool. Do not use if you have had adenomas, have inflammatory bowel disease and certain hereditary syndromes, or a personal or family history of colorectal cancer. A Cologuard test is not a replacement for colonoscopy in high-risk patients. Cologuard test performance in adults ages 45-49 is estimated based on a large clinical study of patients 50 and older.

The Cologuard test result should be interpreted with caution. A positive test result does not confirm the presence of cancer. Patients with a positive test result should be referred for colonoscopy. A negative test result does not confirm the absence of cancer. Patients with a negative test result should discuss with their doctor when they need to be tested again. False positives and false negative results can occur. In a clinical study, 13% of people without cancer received a positive result (false positive) and 8% of people with cancer received a negative result (false negative). Rx only.

Top photo courtesy Exact Sciences

REFERENCES

  1. National Cancer Institute. Cancer Stat Facts: Common Cancer Sites. 2024.
  2. American Cancer Society. Cancer Facts & Figures for Hispanic/Latino People 2021-2023. 2021.
  3. U.S. Census. Annual Estimates of the Resident Population by Sex, Age, Race, and Hispanic Origin of the United States: April 1, 2020 to July 1, 2023. 2020.
  4. Colon Cancer Coalition. Get the Facts About Colon Cancer. 2024.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.55
+0.00 (0.00%)
AAPL  267.44
+0.00 (0.00%)
AMD  230.29
+0.00 (0.00%)
BAC  51.64
+0.00 (0.00%)
GOOG  284.96
+0.00 (0.00%)
META  597.69
+0.00 (0.00%)
MSFT  493.79
+0.00 (0.00%)
NVDA  181.36
+0.00 (0.00%)
ORCL  220.49
+0.00 (0.00%)
TSLA  401.25
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.